<DOC>
	<DOCNO>NCT01806129</DOCNO>
	<brief_summary>This clinical trial study reproductive health program patient cancer . A reproductive health program may improve patient ' understanding reproductive risk receipt appropriate treatment achieve reproductive health goal</brief_summary>
	<brief_title>Reproductive Health Program Patients With Cancer</brief_title>
	<detailed_description>PRIMARY OBJECTIVES : I . To evaluate success implementation reproductive health programming ( Didactics , Engendering Reproductive Health Within Oncologic Survivorship [ EROS ] Reproductive Health Assessment EROS Trial Algorithm ) among reproductive age woman ( 18-55 ) cancer . SECONDARY OBJECTIVES : I . To assess degree discrepancy patient clinicians estimate significance reproductive health goal patient . II . To evaluate baseline follow-up reproductive health assessment trend reproductive health choice relate oncofertility , oncocontraception pregnancy 5 year study period . III . To identify clinical demographic factor predict adequacy reproductive health care management . TERTIARY OBJECTIVES : I . To perform longitudinal study follow endocrine marker fertility cohort first 200 register EROS trial patient agree participate . II . To perform longitudinal study sexual function use Patient-Reported Outcomes Measurement Information System ( PROMIS ) sexual function survey subject participate EROS Trial . OUTLINE : Patients randomize 1 2 arm . ARM A : Patients undergo usual standard practice relate reproductive health . ARM B : Patients undergo reproductive health program comprising didactics , reproductive health assessment navigate algorithm , network development . After completion study treatment , patient follow periodically .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Female patient present initial diagnosis type cancer ( 3 month diagnosis , applicable , initiation chemotherapy radiation ) Premenopausal patient within reproductive age range Pregnant woman eligible participate study Patients must cognitive ability participate study Patients must prior hysterectomy , bilateral oophorectomy sterilization method ( include partner sterilization )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>